GR3029374T3 - Immortalization of denditric cells with v-myc oncogene - Google Patents
Immortalization of denditric cells with v-myc oncogeneInfo
- Publication number
- GR3029374T3 GR3029374T3 GR990400460T GR990400460T GR3029374T3 GR 3029374 T3 GR3029374 T3 GR 3029374T3 GR 990400460 T GR990400460 T GR 990400460T GR 990400460 T GR990400460 T GR 990400460T GR 3029374 T3 GR3029374 T3 GR 3029374T3
- Authority
- GR
- Greece
- Prior art keywords
- pct
- immortalization
- myc oncogene
- sec
- cells
- Prior art date
Links
- 108700024542 myc Genes Proteins 0.000 title 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 238000001994 activation Methods 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 210000004443 dendritic cell Anatomy 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4242—Transcription factors, e.g. SOX or c-MYC
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT93MI001118A IT1264516B1 (it) | 1993-05-31 | 1993-05-31 | Cellule dendritiche immortalizzate |
| PCT/EP1994/001720 WO1994028113A1 (en) | 1993-05-31 | 1994-05-26 | Immortalization of denditric cells with v-myc oncogene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3029374T3 true GR3029374T3 (en) | 1999-05-28 |
Family
ID=11366291
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR990400460T GR3029374T3 (en) | 1993-05-31 | 1999-02-11 | Immortalization of denditric cells with v-myc oncogene |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US5856180A (el) |
| EP (1) | EP0701604B1 (el) |
| JP (1) | JP3834059B2 (el) |
| KR (1) | KR100353220B1 (el) |
| AT (1) | ATE173294T1 (el) |
| AU (1) | AU686636B2 (el) |
| CA (1) | CA2164102A1 (el) |
| DE (1) | DE69414572T2 (el) |
| DK (1) | DK0701604T3 (el) |
| ES (1) | ES2126118T3 (el) |
| GR (1) | GR3029374T3 (el) |
| HU (1) | HUT73322A (el) |
| IT (1) | IT1264516B1 (el) |
| WO (1) | WO1994028113A1 (el) |
| ZA (1) | ZA943782B (el) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4337396A1 (de) | 1993-10-26 | 1995-04-27 | Beiersdorf Ag | Humane Zellinien mit Langerhans-Zell-Charakteristik |
| US5648219A (en) * | 1995-06-07 | 1997-07-15 | Zymogenetics, Inc. | Immortalized dendritic cells |
| US5648248A (en) * | 1994-12-30 | 1997-07-15 | Boehringer Ingelheim International Gmbh | Methods for producing differentiated cells from immature hematopoietic cells |
| US5723333A (en) * | 1995-02-10 | 1998-03-03 | Regents Of The University Of California | Human pancreatic cell lines: developments and uses |
| EP0808364B1 (en) * | 1995-02-10 | 2005-11-30 | The Regents of the University of California | Human pancreatic cell lines: developments and uses |
| AU4977896A (en) * | 1995-02-17 | 1996-09-04 | Immunotherapy, Inc. | Immunotherapy screening, prognosis, and treatment methods and compositions |
| US5849589A (en) * | 1996-03-11 | 1998-12-15 | Duke University | Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells |
| KR20000022445A (ko) * | 1996-07-10 | 2000-04-25 | 크리스토퍼 엘. 와이트, 스코트 지. 홀퀴스트, 스티븐 엘. 말라스카 | 수상돌기 세포의 활성화 방법 |
| US6017527A (en) * | 1996-07-10 | 2000-01-25 | Immunex Corporation | Activated dendritic cells and methods for their activation |
| ATE388237T1 (de) | 1997-04-15 | 2008-03-15 | Dana Farber Cancer Inst Inc | Dendritische zellhybride |
| US20050169898A1 (en) | 1997-04-15 | 2005-08-04 | Jianlin Gong | Cell fusions and methods of making and using the same |
| US7014848B1 (en) | 1998-03-20 | 2006-03-21 | Genzyme Corporation | Enhanced anti-tumor immunity |
| CA2322660A1 (en) * | 1998-03-20 | 1999-09-23 | Genzyme Corporation | Enhanced anti-tumor immunity |
| US7402307B2 (en) | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
| WO1999050392A1 (en) | 1998-03-31 | 1999-10-07 | Geron Corporation | Methods and compositions for eliciting an immune response to a telomerase antigen |
| US6387888B1 (en) * | 1998-09-30 | 2002-05-14 | American Foundation For Biological Research, Inc. | Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen |
| AU3069302A (en) * | 2000-12-13 | 2002-06-24 | Immunex Corp | Method for generating immortal dendritic cell lines |
| EP1417229B1 (en) | 2001-08-17 | 2011-06-15 | Exothera L.L.C. | Methods and compounds for the targeting of protein to exosomes |
| US8095735B2 (en) | 2008-08-05 | 2012-01-10 | Convey Computer | Memory interleave for heterogeneous computing |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5648219A (en) * | 1995-06-07 | 1997-07-15 | Zymogenetics, Inc. | Immortalized dendritic cells |
| US5648248A (en) * | 1994-12-30 | 1997-07-15 | Boehringer Ingelheim International Gmbh | Methods for producing differentiated cells from immature hematopoietic cells |
-
1993
- 1993-05-31 IT IT93MI001118A patent/IT1264516B1/it active IP Right Grant
-
1994
- 1994-05-26 EP EP94917670A patent/EP0701604B1/en not_active Expired - Lifetime
- 1994-05-26 JP JP50023195A patent/JP3834059B2/ja not_active Expired - Fee Related
- 1994-05-26 ES ES94917670T patent/ES2126118T3/es not_active Expired - Lifetime
- 1994-05-26 CA CA002164102A patent/CA2164102A1/en not_active Abandoned
- 1994-05-26 US US08/549,666 patent/US5856180A/en not_active Expired - Fee Related
- 1994-05-26 WO PCT/EP1994/001720 patent/WO1994028113A1/en not_active Ceased
- 1994-05-26 DK DK94917670T patent/DK0701604T3/da active
- 1994-05-26 AT AT94917670T patent/ATE173294T1/de not_active IP Right Cessation
- 1994-05-26 AU AU69299/94A patent/AU686636B2/en not_active Ceased
- 1994-05-26 KR KR1019950705371A patent/KR100353220B1/ko not_active Expired - Fee Related
- 1994-05-26 DE DE69414572T patent/DE69414572T2/de not_active Expired - Fee Related
- 1994-05-26 HU HU9503414A patent/HUT73322A/hu unknown
- 1994-05-30 ZA ZA943782A patent/ZA943782B/xx unknown
-
1998
- 1998-01-02 US US09/002,380 patent/US6156307A/en not_active Expired - Fee Related
-
1999
- 1999-02-11 GR GR990400460T patent/GR3029374T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69414572D1 (de) | 1998-12-17 |
| WO1994028113A1 (en) | 1994-12-08 |
| AU686636B2 (en) | 1998-02-12 |
| IT1264516B1 (it) | 1996-09-24 |
| AU6929994A (en) | 1994-12-20 |
| JP3834059B2 (ja) | 2006-10-18 |
| DE69414572T2 (de) | 1999-07-29 |
| CA2164102A1 (en) | 1994-12-08 |
| ES2126118T3 (es) | 1999-03-16 |
| ITMI931118A0 (it) | 1993-05-31 |
| US6156307A (en) | 2000-12-05 |
| DK0701604T3 (da) | 1999-07-26 |
| EP0701604B1 (en) | 1998-11-11 |
| ATE173294T1 (de) | 1998-11-15 |
| US5856180A (en) | 1999-01-05 |
| JPH09500523A (ja) | 1997-01-21 |
| ITMI931118A1 (it) | 1994-12-01 |
| EP0701604A1 (en) | 1996-03-20 |
| HUT73322A (en) | 1996-07-29 |
| ZA943782B (en) | 1995-02-09 |
| KR100353220B1 (ko) | 2003-12-31 |
| HU9503414D0 (en) | 1996-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9503414D0 (en) | Immortalization of denditric cells with v-myc oncogene | |
| GR3034190T3 (en) | Reconstituted cartilage tissue. | |
| PT716689E (pt) | Processo para a preparacao e cultura de celulas progenitoras hematopoieticas | |
| DE69535328D1 (de) | In-vitro wachstum von langerhans'schen inseln und ihre verwendungen | |
| SG129236A1 (en) | Somatic pluripotent cells | |
| TW260653B (el) | ||
| SG47515A1 (en) | Plant gum material and use thereof in food products | |
| ZA938903B (en) | Lactobacillus sake like strains production and use of their exopolysaccharides | |
| PL327060A1 (en) | Application of 2-ethylhexyl alpha-cyano-beta,beta-diphemylacrylate to improve stability of cosmetic compositions containing p-methylbenzylibene camphor in combination with a derivative of dibenzoyl methane | |
| ATE268811T1 (de) | Therapeutische anwendungen von chimänischer organogenese | |
| EP0747475A3 (en) | Culture slide assembly | |
| EP1270719A3 (en) | Cell population containing non-fetal hemangioblasts and method for producing same | |
| AU6722394A (en) | Electrochemiluminescent process | |
| AU2534595A (en) | Angiotensin ii for improving fertilization | |
| ES2160829T3 (es) | Procedimiento para la obtencion de riboflavina por medio de microorganismos con actividad de isocitratoliasa modificada. | |
| DE69403087D1 (de) | Verfahren zur herstellung von 9-(2-hydroxy)-ethoxy-guanin | |
| BR0008536A (pt) | Usos de um meio de cultura, e de pelo menos um mas, análogo de mas ou um aditivo ou aditivos, e, processo para fertilização in vitro | |
| GB9608143D0 (en) | Assay | |
| AU8478601A (en) | Methods for culturing human lung mast cells and uses thereof | |
| GR3035445T3 (en) | Method of preparing arabinonucleotides | |
| WO1993023529A3 (fr) | Culture stabilisee d'agregats cellulaires et procede de developpement des embryons a partir d'une souche proembryogene destine a la regeneration de la vigne | |
| PT83368A (en) | Process for propagating microorganisms in vivo by using cell lines which lack human class ii histocompatibility antigens | |
| ZA94514B (en) | Process for the production of C-substituted diethylenetriamines | |
| WO2000015767A3 (en) | Antigen-presenting cells and their use in therapy | |
| Chotard‐Ghodsnia et al. | Cyclic AMP‐dependent cell shape changes induced by mechanical forces |